Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-17TPST3Tempest Therapeutics Director John D. Yee Files Late Form 3 for Beneficial Ownership
John D. Yee, a director of Tempest Therapeutics, Inc. (TPST), has filed a late Form 3 statement of beneficial ownership. The filing reports Yee's ownership of securities in the company and is being submitted after the required deadline due to an inadvertent administrative oversight. The period of report is June 4, 2026...
Nano CapBiotechnology
2026-06-17Tempest Therapeutics, Inc.3Tempest Therapeutics Director John D. Yee Files Late Form 3 for Beneficial OwnershipDuplicate
John D. Yee, a director of Tempest Therapeutics, Inc. (TPST), has filed a late Form 3 statement of beneficial ownership. The filing reports Yee's ownership of securities in the company and is being submitted after the required deadline due to an inadvertent administrative oversight. The period of report is June 4, 2026...
Nano CapBiotechnology